List of Chapters/Sections(Table Of Content)
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Parkinson?s Disease Treatment Market Size Analysis from 2022 to 2027
1.5.1 Global Parkinson?s Disease Treatment Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Parkinson?s Disease Treatment Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Parkinson?s Disease Treatment Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Parkinson?s Disease Treatment Industry Impact
Chapter 2 Global Parkinson?s Disease Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Parkinson?s Disease Treatment (Volume and Value) by Type
2.1.1 Global Parkinson?s Disease Treatment Consumption and Market Share by Type (2016-2021)
2.1.2 Global Parkinson?s Disease Treatment Revenue and Market Share by Type (2016-2021)
2.2 Global Parkinson?s Disease Treatment (Volume and Value) by Application
2.2.1 Global Parkinson?s Disease Treatment Consumption and Market Share by Application (2016-2021)
2.2.2 Global Parkinson?s Disease Treatment Revenue and Market Share by Application (2016-2021)
2.3 Global Parkinson?s Disease Treatment (Volume and Value) by Regions
2.3.1 Global Parkinson?s Disease Treatment Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Parkinson?s Disease Treatment Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Parkinson?s Disease Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Parkinson?s Disease Treatment Consumption by Regions (2016-2021)
4.2 North America Parkinson?s Disease Treatment Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Parkinson?s Disease Treatment Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Parkinson?s Disease Treatment Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Parkinson?s Disease Treatment Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Parkinson?s Disease Treatment Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Parkinson?s Disease Treatment Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Parkinson?s Disease Treatment Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Parkinson?s Disease Treatment Sales, Consumption, Export, Import (2016-2021)
4.10 South America Parkinson?s Disease Treatment Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Parkinson?s Disease Treatment Market Analysis
5.1 North America Parkinson?s Disease Treatment Consumption and Value Analysis
5.1.1 North America Parkinson?s Disease Treatment Market Under COVID-19
5.2 North America Parkinson?s Disease Treatment Consumption Volume by Types
5.3 North America Parkinson?s Disease Treatment Consumption Structure by Application
5.4 North America Parkinson?s Disease Treatment Consumption by Top Countries
5.4.1 United States Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
5.4.2 Canada Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
5.4.3 Mexico Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
Chapter 6 East Asia Parkinson?s Disease Treatment Market Analysis
6.1 East Asia Parkinson?s Disease Treatment Consumption and Value Analysis
6.1.1 East Asia Parkinson?s Disease Treatment Market Under COVID-19
6.2 East Asia Parkinson?s Disease Treatment Consumption Volume by Types
6.3 East Asia Parkinson?s Disease Treatment Consumption Structure by Application
6.4 East Asia Parkinson?s Disease Treatment Consumption by Top Countries
6.4.1 China Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
6.4.2 Japan Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
6.4.3 South Korea Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
Chapter 7 Europe Parkinson?s Disease Treatment Market Analysis
7.1 Europe Parkinson?s Disease Treatment Consumption and Value Analysis
7.1.1 Europe Parkinson?s Disease Treatment Market Under COVID-19
7.2 Europe Parkinson?s Disease Treatment Consumption Volume by Types
7.3 Europe Parkinson?s Disease Treatment Consumption Structure by Application
7.4 Europe Parkinson?s Disease Treatment Consumption by Top Countries
7.4.1 Germany Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
7.4.2 UK Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
7.4.3 France Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
7.4.4 Italy Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
7.4.5 Russia Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
7.4.6 Spain Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
7.4.7 Netherlands Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
7.4.8 Switzerland Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
7.4.9 Poland Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
Chapter 8 South Asia Parkinson?s Disease Treatment Market Analysis
8.1 South Asia Parkinson?s Disease Treatment Consumption and Value Analysis
8.1.1 South Asia Parkinson?s Disease Treatment Market Under COVID-19
8.2 South Asia Parkinson?s Disease Treatment Consumption Volume by Types
8.3 South Asia Parkinson?s Disease Treatment Consumption Structure by Application
8.4 South Asia Parkinson?s Disease Treatment Consumption by Top Countries
8.4.1 India Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
8.4.2 Pakistan Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Parkinson?s Disease Treatment Market Analysis
9.1 Southeast Asia Parkinson?s Disease Treatment Consumption and Value Analysis
9.1.1 Southeast Asia Parkinson?s Disease Treatment Market Under COVID-19
9.2 Southeast Asia Parkinson?s Disease Treatment Consumption Volume by Types
9.3 Southeast Asia Parkinson?s Disease Treatment Consumption Structure by Application
9.4 Southeast Asia Parkinson?s Disease Treatment Consumption by Top Countries
9.4.1 Indonesia Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
9.4.2 Thailand Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
9.4.3 Singapore Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
9.4.4 Malaysia Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
9.4.5 Philippines Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
9.4.6 Vietnam Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
9.4.7 Myanmar Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
Chapter 10 Middle East Parkinson?s Disease Treatment Market Analysis
10.1 Middle East Parkinson?s Disease Treatment Consumption and Value Analysis
10.1.1 Middle East Parkinson?s Disease Treatment Market Under COVID-19
10.2 Middle East Parkinson?s Disease Treatment Consumption Volume by Types
10.3 Middle East Parkinson?s Disease Treatment Consumption Structure by Application
10.4 Middle East Parkinson?s Disease Treatment Consumption by Top Countries
10.4.1 Turkey Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
10.4.3 Iran Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
10.4.5 Israel Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
10.4.6 Iraq Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
10.4.7 Qatar Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
10.4.8 Kuwait Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
10.4.9 Oman Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
Chapter 11 Africa Parkinson?s Disease Treatment Market Analysis
11.1 Africa Parkinson?s Disease Treatment Consumption and Value Analysis
11.1.1 Africa Parkinson?s Disease Treatment Market Under COVID-19
11.2 Africa Parkinson?s Disease Treatment Consumption Volume by Types
11.3 Africa Parkinson?s Disease Treatment Consumption Structure by Application
11.4 Africa Parkinson?s Disease Treatment Consumption by Top Countries
11.4.1 Nigeria Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
11.4.2 South Africa Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
11.4.3 Egypt Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
11.4.4 Algeria Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
11.4.5 Morocco Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
Chapter 12 Oceania Parkinson?s Disease Treatment Market Analysis
12.1 Oceania Parkinson?s Disease Treatment Consumption and Value Analysis
12.2 Oceania Parkinson?s Disease Treatment Consumption Volume by Types
12.3 Oceania Parkinson?s Disease Treatment Consumption Structure by Application
12.4 Oceania Parkinson?s Disease Treatment Consumption by Top Countries
12.4.1 Australia Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
12.4.2 New Zealand Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
Chapter 13 South America Parkinson?s Disease Treatment Market Analysis
13.1 South America Parkinson?s Disease Treatment Consumption and Value Analysis
13.1.1 South America Parkinson?s Disease Treatment Market Under COVID-19
13.2 South America Parkinson?s Disease Treatment Consumption Volume by Types
13.3 South America Parkinson?s Disease Treatment Consumption Structure by Application
13.4 South America Parkinson?s Disease Treatment Consumption Volume by Major Countries
13.4.1 Brazil Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
13.4.2 Argentina Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
13.4.3 Columbia Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
13.4.4 Chile Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
13.4.5 Venezuela Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
13.4.6 Peru Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
13.4.8 Ecuador Parkinson?s Disease Treatment Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Parkinson?s Disease Treatment Business
14.1 UCB
14.1.1 UCB Company Profile
14.1.2 UCB Parkinson?s Disease Treatment Product Specification
14.1.3 UCB Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 AbbVie
14.2.1 AbbVie Company Profile
14.2.2 AbbVie Parkinson?s Disease Treatment Product Specification
14.2.3 AbbVie Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Acorda Therapeutics
14.3.1 Acorda Therapeutics Company Profile
14.3.2 Acorda Therapeutics Parkinson?s Disease Treatment Product Specification
14.3.3 Acorda Therapeutics Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Roche
14.4.1 Roche Company Profile
14.4.2 Roche Parkinson?s Disease Treatment Product Specification
14.4.3 Roche Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Teva
14.5.1 Teva Company Profile
14.5.2 Teva Parkinson?s Disease Treatment Product Specification
14.5.3 Teva Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Prothena
14.6.1 Prothena Company Profile
14.6.2 Prothena Parkinson?s Disease Treatment Product Specification
14.6.3 Prothena Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Orion Pharmaceuticals
14.7.1 Orion Pharmaceuticals Company Profile
14.7.2 Orion Pharmaceuticals Parkinson?s Disease Treatment Product Specification
14.7.3 Orion Pharmaceuticals Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Impax Pharmaceuticals
14.8.1 Impax Pharmaceuticals Company Profile
14.8.2 Impax Pharmaceuticals Parkinson?s Disease Treatment Product Specification
14.8.3 Impax Pharmaceuticals Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Voyager Therapeutics
14.9.1 Voyager Therapeutics Company Profile
14.9.2 Voyager Therapeutics Parkinson?s Disease Treatment Product Specification
14.9.3 Voyager Therapeutics Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 MSD
14.10.1 MSD Company Profile
14.10.2 MSD Parkinson?s Disease Treatment Product Specification
14.10.3 MSD Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Sunovion
14.11.1 Sunovion Company Profile
14.11.2 Sunovion Parkinson?s Disease Treatment Product Specification
14.11.3 Sunovion Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Intec Pharma
14.12.1 Intec Pharma Company Profile
14.12.2 Intec Pharma Parkinson?s Disease Treatment Product Specification
14.12.3 Intec Pharma Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 GSK
14.13.1 GSK Company Profile
14.13.2 GSK Parkinson?s Disease Treatment Product Specification
14.13.3 GSK Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Acadia
14.14.1 Acadia Company Profile
14.14.2 Acadia Parkinson?s Disease Treatment Product Specification
14.14.3 Acadia Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 NeuroDerm
14.15.1 NeuroDerm Company Profile
14.15.2 NeuroDerm Parkinson?s Disease Treatment Product Specification
14.15.3 NeuroDerm Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Adamas Therapeutics
14.16.1 Adamas Therapeutics Company Profile
14.16.2 Adamas Therapeutics Parkinson?s Disease Treatment Product Specification
14.16.3 Adamas Therapeutics Parkinson?s Disease Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Parkinson?s Disease Treatment Market Forecast (2022-2027)
15.1 Global Parkinson?s Disease Treatment Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Parkinson?s Disease Treatment Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Parkinson?s Disease Treatment Value and Growth Rate Forecast (2022-2027)
15.2 Global Parkinson?s Disease Treatment Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Parkinson?s Disease Treatment Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Parkinson?s Disease Treatment Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Parkinson?s Disease Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Parkinson?s Disease Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Parkinson?s Disease Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Parkinson?s Disease Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Parkinson?s Disease Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Parkinson?s Disease Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Parkinson?s Disease Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Parkinson?s Disease Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Parkinson?s Disease Treatment Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Parkinson?s Disease Treatment Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Parkinson?s Disease Treatment Consumption Forecast by Type (2022-2027)
15.3.2 Global Parkinson?s Disease Treatment Revenue Forecast by Type (2022-2027)
15.3.3 Global Parkinson?s Disease Treatment Price Forecast by Type (2022-2027)
15.4 Global Parkinson?s Disease Treatment Consumption Volume Forecast by Application (2022-2027)
15.5 Parkinson?s Disease Treatment Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
